Safety and Efficacy of Convalescent Plasma to Treat Severe COVID-19: Protocol for the Saudi Collaborative Multicenter Phase II Study
JMIR Research Protocols2020Vol. 9(10), pp. e23543–e23543
Citations Over Time
Mohammed Albalawi, Syed Ziauddin A. Zaidi, Nawal F Alshehry, Ahmed Alaskar, Abdul Rehman Zia Zaidi, Rania Nagib Mohammed Abdallah, Abdul Salam, Ahmed AlSagheir, Nour AlMozain, Ghada Elgohary, Khalid Batarfi, Alia Alfaraedi, Osamah T. Khojah, Rehab Y. Al‐Ansari, Mona Alfaraj, Afra Dayel, A. Bahranı, Arwa Nabhan Abdelhameed, Hind Alhumaidan, Jawaher Alotaibi, Ghazala Radwi, Abdulrahman Al Raizah, Hind Shatry, Sara Alsaleh, Hazzaa Alzahrani, Hani Alhashmi
Abstract
PRR1-10.2196/23543.
Related Papers
- → What if the worst consequences of COVID-19 concerned non-COVID patients?(2020)22 cited
- → Adult’s Perception of Every Day Life Change After COVID-19(2022)1 cited
- → ХАРАКТЕРИСТИКА ОЧАГОВ COVID-19 С РАСПРОСТРАНЕНИЕМ В ОРГАНИЗОВАННЫХ КОЛЛЕКТИВАХ, ЗАРЕГИСТРИРОВАННЫХ В ХАБАРОВСКОМ КРАЕ В ПЕРИОД С АПРЕЛЯ ПО СЕНТЯБРЬ 2020 Г.(2020)
- → COVID–19流行下における自殺企図患者の推移(Changes in suicide attempt patients during the COVID–19 pandemic)(2022)
- → Pediatricians Face Challenges in Diagnosing Post-COVID-19 Conditions (Long COVID)(2023)